Giovanni Scaglione

Dr. Giovanni Scaglione

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FPFlavia Pennisi
Flavia Pennisi
APAntonio Pinto
Antonio Pinto
FBFabio Borgonovo
Fabio Borgonovo
GSGiovanni Scaglione
Giovanni Scaglione
RLRiccardo Ligresti
Riccardo Ligresti
VGVincenza Gianfredi
Vincenza Gianfredi
Background: Mosquito-borne viral diseases are a growing global health threat, and artificial intelligence (AI) and machine learning (ML) are increasingly proposed as forecasting tools to support early-warning and response. However, the available evidence is fragmented across pathogens, settings and modelling approaches. This review provides, to the best of our knowledge, the first comprehensive comparative assessment of AI/ML models forecasting mosquito-borne viral diseases in human populations, jointly synthesising predictive performance across model families and appraising both methodological quality and operational readiness. Methods: Following PRISMA 2020, we searched PubMed, Embase and Scopus up to August 2025. We included studies applying AI/ML or statistical models to predict arboviral incidence, outbreaks or temporal trends and reporting at least one quantitative performance metric. Given the substantial heterogeneity in outcomes, predictors and time–space scales, we conducted a descriptive synthesis. Risk of bias and applicability were evaluated using PROBAST. Results: Ninety-eight studies met the inclusion criteria, of which 91 focused on dengue. The forecasts spanned national to city-level settings and annual-to-weekly resolutions. Across classification tasks, tree-ensemble models showed the most consistent performance, with accuracies typically above 0.85, while classical ML and deep-learning models showed wider variability. For regression tasks, errors increased with temporal horizon and spatial aggregation: short-term, fine-scale forecasts (e.g., weekly city level) often achieved low absolute errors, whereas long-horizon national models frequently exhibited very large errors and unstable performance. PROBAST assessment indicated that most studies (63/98) were at high risk of bias, with only 24 judged at low risk and limited external validation. Conclusions: AI/ML models, especially tree-ensemble approaches, show strong potential for short-term, fine-scale forecasting, but their reliability drops substantially at broader spatial and temporal scales. Most remain research-stage, with limited external validation and minimal operational deployment. This review clarifies current capabilities and highlights three priorities for real-world use: standardised reporting, rigorous external validation, and context-specific calibration.

6 August 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
GSGiovanni Scaglione
Giovanni Scaglione
MCMarta Colaneri
Marta Colaneri
MOMARTINA OFFER
MARTINA OFFER
LGLucia Galli
Lucia Galli
FBFabio Borgonovo
Fabio Borgonovo
AFAntonella Foschi
Antonella Foschi
Introduction: Vascular access devices (VADs), namely peripheral VADs (PVADs) and central venous VADs (CVADs), are crucial in both intensive care unit (ICU) and non-ICU settings. However, VAD placement carries risks, notably catheter-related bloodstream infections (CRBSIs). Candida spp. is a common pathogen in CRBSIs, yet its clinical and microbiological characteristics, especially in non-ICU settings, are underexplored. Methods: We conducted a monocentric, retrospective observational study at Luigi Sacco Hospital from 1 May 2021 to 1 September 2023. We reviewed medical records of non-ICU adult patients with CVADs and PVADs. Data on demographics, clinical and laboratory results, VAD placement, and CRBSI occurrences were collected. Statistical analysis compared Candida spp. CRBSI and bacterial CRBSI groups. Results: Out of 1802 VAD placements in 1518 patients, 54 cases of CRBSI were identified, and Candida spp. was isolated in 30.9% of episodes. The prevalence of CRBSI was 3.05%, with Candida spp. accounting for 0.94%. Incidence rates were 2.35 per 1000 catheter days for CRBSI, with Candida albicans and Candida non-albicans at 0.47 and 0.26 per 1000 catheter days, respectively—patients with Candida spp. CRBSI had more frequent SARS-CoV-2 infection, COVID-19 pneumonia, and hypoalbuminemia. Conclusions: During the COVID-19 pandemic, Candida spp. was a notable cause of CRBSIs in our center, underscoring the importance of considering Candida spp. in suspected CRBSI cases, including those in non-ICU settings and in those with PVADs.

6 June 2025 in American Journal of Infection Control
Verified
Journal Article
Closed access
FBFabio Borgonovo
Fabio Borgonovo
MCMarta Colaneri
Marta Colaneri
FFFederico Fassio
Federico Fassio
GSGiovanni Scaglione
Giovanni Scaglione
LGLucia Galli
Lucia Galli
AFAntonella Foschi
Antonella Foschi

3 January 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
MCMarta Colaneri
Marta Colaneri
LGLucia Galli
Lucia Galli
MOMARTINA OFFER
MARTINA OFFER
FBFabio Borgonovo
Fabio Borgonovo
GSGiovanni Scaglione
Giovanni Scaglione
AFAntonella Foschi
Antonella Foschi
Introduction: Vascular access device (VAD)-associated infections, including catheter-related (CRBSI) and catheter-associated bloodstream infections (CABSI), present significant challenges in patient care. While multidisciplinary VAD teams (VATs) are equipped with protocols for managing these infections, adherence to these guidelines in real-life practice is inconsistent. This study aims to evaluate the alignment between actual VAD infection management practices and VAT-recommended protocols. Methods: We conducted a retrospective, single-center study at Luigi Sacco Hospital (May 2021–October 2023) involving non-ICU adult patients with diagnosed CRBSI or CABSI. VAT experts independently reviewed infection management choices, which were divided into eight specific procedural options. These options included variations in VAD removal, timing of repositioning, and combinations of antimicrobial lock therapy and systemic therapy. Concordance between real-life practices and VAT recommendations was evaluated using Cohen’s kappa coefficient. Results: Of 2419 VAD placements, 146 (6%) developed infections (84 CABSI, 62 CRBSI). Clinicians removed VADs in 66.4% of cases compared to 62.3% per VAT recommendations, with moderate overall agreement (Cohen’s kappa = 0.58). Analysis of the eight management categories revealed moderate to low alignment (unweighted kappa = 0.44, weighted kappa = 0.30) between real-life practices and VAT guidance, with slightly improved concordance in CRBSI cases. Conclusions: Our findings underscore a discrepancy between real-life VAD infection management and VAT-recommended protocols, suggesting a need for clearer, more accessible guidelines and increased multidisciplinary collaboration. Enhanced VAT consultation and simplified protocol dissemination may improve consistency in infection management and ultimately lead to better patient outcomes.

7 May 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
GCGiovanni De Capitani
Giovanni De Capitani
MCMarta Colaneri
Marta Colaneri
CCClaudia Conflitti
Claudia Conflitti
FBFabio Borgonovo
Fabio Borgonovo
LGLucia Galli
Lucia Galli
AFAntonella Foschi
Antonella Foschi
Catheter-associated bloodstream infections (CABSIs) and catheter-related bloodstream infections (CRBSIs) are significant causes of morbidity and mortality worldwide. The current practice favors the removal of vascular access devices (VADs); however, the evidence on this topic remains inconclusive. This study evaluates the clinical outcomes in terms of in-hospital mortality and catheter retention vs. removal in CABSI and CRBSI cases. A retrospective, observational, single-center study was conducted at Luigi Sacco Hospital, Milan, Italy (May 2021–December 2023), and it analyzed non-ICU adult patients with VADs diagnosed with CRBSIs or CABSIs. Clinical and microbiological data were collected to assess the outcomes based on catheter management. Among 1874 patients with VADs, 147 were included, with 164 VAD infection events (92 CABSIs and 72 CRBSIs). Overall, 35 (23.8%) patients with CABSIs and CRBSIs died. Out of those who retained the catheter 19 (35.8%) patients died, while among removal patients 16 (17%) died (p = 0.018). A Candida spp. isolation was found to be significantly associated with a higher likelihood of catheter removal (p = 0.04). Our findings suggest that, in non-ICU CRBSI and CABSI cases, VAD removal may be associated with improved outcomes when feasible.

14 October 2026 in Frontiers in Reproductive Health
Verified
Journal Article
Open access
PDF file
GSGiovanni Scaglione
Giovanni Scaglione
FFFederico Fama
Federico Fama
LCLoredana Catinari
Loredana Catinari
CCClaudia Conflitti
Claudia Conflitti
SCStefania Caronni
Stefania Caronni
CAChiara Atzori
Chiara Atzori
Introduction: Transgender women experience a disproportionate burden of HIV infection and intersecting social vulnerabilities. While virological outcomes among those retained in care are increasingly documented, data integrating neuropsychological health and socioeconomic determinants, particularly in European settings, remain scarce. Suboptimal cognitive performance may persist despite viral suppression, potentially undermining quality of life and long-term engagement in care. We aim to provide an integrated characterization of the immunovirological, neuropsychological, and socioeconomic profile of TW living with HIV attending a tertiary HIV reference center. Methods: We conducted a retrospective cross-sectional study at the outpatient HIV clinic of Luigi Sacco University Hospital, Milan, between 2011 and 2023. We included adult TW living with HIV who had adequate proficiency in Italian and had undergone standardized neuropsychological assessment. Clinical, immunovirological, neuropsychological, and socioeconomic data were extracted from medical records and analyzed descriptively. Results: Ninety-five participants were included, predominantly Latin American migrants (95.8%) engaged in sex work (95.6%), with high rates of regular substance use (69.5%). Most participants were virologically suppressed at the time of neuropsychological assessment (78.5%), and nearly all had CD4 counts above 200 cells/µL (97.9%). Nonetheless, performances below normative thresholds were frequently observed, particularly on tests assessing processing speed and sustained attention (45.3%) and immediate verbal memory (60.0%). Sixty percent of participants (51/85) self-reported at least one complaint across memory, attention, and mental speed domains. Among participants with below-threshold performances immunovirological characteristics appeared broadly comparable to those with preserved performances across all tests, whereas benzodiazepine use was numerically more prevalent on 6 out of 8 measures, followed by regular substance use to a lesser extent. Educational attainment showed no consistent direction across tests. Conclusions: In this clinic-based population of TW living with HIV, performances below normative thresholds across several neuropsychological measures and marked socioeconomic vulnerability were frequently observed despite generally favorable virological outcomes. These findings support the integration of neuropsychological evaluation, substance use assessment, and gender-affirming services into comprehensive, multidisciplinary HIV care models for this population.